Immune ageing, dysmetabolism and inflammation in neurological diseases

Frontiers in Neuroscience

Volumn 9, Issue APR, 2015, Pages

  Deleidi, Michela ^a,b   Jäggle, Madeline ^a,b   Rubino, Graziella ^c  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Ageing; Brain immune interactions; Immunosenescence; Inflammation; Metabolism; Neurodegenerative diseases; Neuropsychiatric diseases

Indexed keywords

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN CELL; CELL AGING; DEGENERATIVE DISEASE; HUMAN; IMMUNE DYSREGULATION; INFLAMMATION; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; OBESITY; PARKINSON DISEASE;

EID: 84928730412     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00172     Document Type: Article

References (223)

1. Abu-Taha M, Rius C, Hermenegildo C, Noguera I, Cerda-Nicolas JM, Issekutz AC, Jose PJ, Cortijo J, Morcillo EJ and Sanz MJ (2009) Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. Journal of immunology 183:1393-1402.
2. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Fumagalli M, Da Costa M, Brown C, Popov N, Takatsu Y, Melamed J, d'Adda di Fagagna F, Bernard D, Hernando E and Gil J (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133:1006-1018.
3. Alzheimer's Disease Anti-inflammatory Prevention Trial Research G (2013) Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT). Alzheimer's & dementia: the journal of the Alzheimer's Association 9:714-723.
4. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ and Rowland-Jones SL (2002) Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nature medicine 8:379-385.
5. Appay V, Fastenackels S, Katlama C, Ait-Mohand H, Schneider L, Guihot A, Keller M, Grubeck-Loebenstein B, Simon A, Lambotte O, Hunt PW, Deeks SG, Costagliola D, Autran B and Sauce D (2011) Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. AIDS 25:1813-1822.
6. Arnold CR, Wolf J, Brunner S, Herndler-Brandstetter D and Grubeck-Loebenstein B (2011) Gain and loss of T cell subsets in old age--age-related reshaping of the T cell repertoire. Journal of clinical immunology 31:137-146.
7. Arruda AP, Pers BM, Parlakgul G, Guney E, Inouye K and Hotamisligil GS (2014) Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nature medicine 20:1427-1435.
8. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA and Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Archives of neurology 61:661-666.
9. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN and Van de Water J (2011) Altered T cell responses in children with autism. Brain, behavior, and immunity 25:840-849.
10. Barger SW and Harmon AD (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388:878-881.
11. Bartlett DB, Firth CM, Phillips AC, Moss P, Baylis D, Syddall H, Sayer AA, Cooper C and Lord JM (2012) The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging cell 11:912-915.
12. Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, Liao B and Appel SH (2011) Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain 134:1293-1314.
13. Belbasis L, Bellou V, Evangelou E, Ioannidis JP and Tzoulaki I (2015) Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and metaanalyses. Lancet Neurol 14:263-273.
14. Benner EJ, Banerjee R, Reynolds AD, Sherman S, Pisarev VM, Tsiperson V, Nemachek C, Ciborowski P, Przedborski S, Mosley RL and Gendelman HE (2008) Nitrated alphasynuclein immunity accelerates degeneration of nigral dopaminergic neurons. PloS one 3:e1376.
15. Beraud D, Twomey M, Bloom B, Mittereder A, Ton V, Neitzke K, Chasovskikh S, Mhyre TR and Maguire-Zeiss KA (2011) alpha-Synuclein Alters Toll-Like Receptor Expression. Front Neurosci 5:80.
16. Beumer W, Drexhage RC, De Wit H, Versnel MA, Drexhage HA and Cohen D (2012a) Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology 37:1901-1911.
17. Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, Steiner J, Connor TJ, Harkin A, Versnel MA and Drexhage HA (2012b) The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. Journal of leukocyte biology 92:959-975.
18. Bhadra R, Cobb DA, Weiss LM and Khan IA (2013) Psychiatric disorders in toxoplasma seropositive patients--the CD8 connection. Schizophrenia bulletin 39:485-489.
19. Bhadra R, Gigley JP, Weiss LM and Khan IA (2011) Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci U S A 108:9196-9201.
20. Bonotis K, Krikki E, Holeva V, Aggouridaki C, Costa V and Baloyannis S (2008) Systemic immune aberrations in Alzheimer's disease patients. Journal of neuroimmunology 193:183-187.
21. Braak H, de Vos RA, Bohl J and Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neuroscience letters 396:67-72.
22. Braunschweig D and Van de Water J (2012) Maternal autoantibodies in autism. Archives of neurology 69:693-699.
23. Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D, Callebert J, Launay JM, Duyckaerts C, Flavell RA, Hirsch EC and Hunot S (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. The Journal of clinical investigation 119:182-192.
24. Brunk UT and Terman A (2002) The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. European journal of biochemistry/FEBS 269:1996-2002.
25. Brydon L, Harrison NA, Walker C, Steptoe A and Critchley HD (2008) Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biological psychiatry 63:1022-1029.
26. Butcher SK, Chahal H, Nayak L, Sinclair A, Henriquez NV, Sapey E, O'Mahony D and Lord JM (2001) Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. Journal of leukocyte biology 70:881-886.
27. Calopa M, Bas J, Callen A and Mestre M (2010) Apoptosis of peripheral blood lymphocytes in Parkinson patients. Neurobiol Dis 38:1-7.
28. Capuron L, Poitou C, Machaux-Tholliez D, Frochot V, Bouillot JL, Basdevant A, Laye S and Clement K (2011) Relationship between adiposity, emotional status and eating behaviour in obese women: role of inflammation. Psychological medicine 41:1517-1528.
29. Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ, Maisano C, Jones L, Murrah NV and Vaccarino V (2008) Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biological psychiatry 64:896-900.
30. Carbone F, La Rocca C and Matarese G (2012) Immunological functions of leptin and adiponectin. Biochimie 94:2082-2088.
31. Carter CJ (2009) Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophrenia bulletin 35:1163-1182.
32. Cereda E, Barichella M, Cassani E, Caccialanza R and Pezzoli G (2012) Clinical features of Parkinson disease when onset of diabetes came first: A case-control study. Neurology 78:1507-1511.
33. Chen H, Zhang SM, Hernan MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE and Ascherio A (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Archives of neurology 60:1059-1064.
34. Chinta SJ, Woods G, Rane A, Demaria M, Campisi J and Andersen JK (2014) Cellular senescence and the aging brain. Experimental gerontology.
35. Chiu IM, Phatnani H, Kuligowski M, Tapia JC, Carrasco MA, Zhang M, Maniatis T and Carroll MC (2009) Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc Natl Acad Sci U S A 106:20960-20965.
36. Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L and de Bernard M (2013) Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PloS one 8:e55375.
37. Cohen S, Janicki-Deverts D, Doyle WJ, Miller GE, Frank E, Rabin BS and Turner RB (2012) Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci U S A 109:5995-5999.
38. Cohen S, Tyrrell DA and Smith AP (1991) Psychological stress and susceptibility to the common cold. The New England journal of medicine 325:606-612.
39. Colman RJ, Beasley TM, Kemnitz JW, Johnson SC, Weindruch R and Anderson RM (2014) Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nature communications 5:3557.
40. Colonna M (2003) TREMs in the immune system and beyond. Nature reviews Immunology 3:445-453.
41. Conde JR and Streit WJ (2006) Microglia in the aging brain. Journal of neuropathology and experimental neurology 65:199-203.
42. Cote S, Carmichael PH, Verreault R, Lindsay J, Lefebvre J and Laurin D (2012) Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association 8:219-226.
43. Cotman CW, Berchtold NC and Christie LA (2007) Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends in neurosciences 30:464-472.
44. Cutuli D, De Bartolo P, Caporali P, Laricchiuta D, Foti F, Ronci M, Rossi C, Neri C, Spalletta G, Caltagirone C, Farioli-Vecchioli S and Petrosini L (2014) n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. Frontiers in aging neuroscience 6:220.
45. Damani MR, Zhao L, Fontainhas AM, Amaral J, Fariss RN and Wong WT (2011) Agerelated alterations in the dynamic behavior of microglia. Aging cell 10:263-276.
46. Deeks SG and Phillips AN (2009) HIV infection, antiretroviral treatment, ageing, and non- AIDS related morbidity. BMJ 338:a3172.
47. Deleidi M and Gasser T (2013) The role of inflammation in sporadic and familial Parkinson's disease. Cell Mol Life Sci.
48. Deleidi M, Hallett PJ, Koprich JB, Chung CY and Isacson O (2010) The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration. The Journal of neuroscience: the official journal of the Society for Neuroscience 30:16091-16101.
49. Deleidi M and Isacson O (2012) Viral and inflammatory triggers of neurodegenerative diseases. Science translational medicine 4:121ps123.
50. Derhovanessian E, Maier AB, Beck R, Jahn G, Hahnel K, Slagboom PE, de Craen AJ, Westendorp RG and Pawelec G (2010) Hallmark features of immunosenescence are absent in familial longevity. Journal of immunology 185:4618-4624.
51. Derhovanessian E, Maier AB, Hahnel K, Beck R, de Craen AJ, Slagboom EP, Westendorp RG and Pawelec G (2011) Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. The Journal of general virology 92:2746-2756.
52. Dobbs RJ, Charlett A, Purkiss AG, Dobbs SM, Weller C and Peterson DW (1999) Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. Acta neurologica Scandinavica 100:34-41.
53. Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA and Klein HC (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 50:1801-1807.
54. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK and Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biological psychiatry 67:446-457.
55. Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP and Meininger V (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70:1004-1009.
56. Dupuis L, Pradat PF, Ludolph AC and Loeffler JP (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10:75-82.
57. Dykstra B, Olthof S, Schreuder J, Ritsema M and de Haan G (2011) Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. The Journal of experimental medicine 208:2691-2703.
58. Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E and Mortensen PB (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. The American journal of psychiatry 163:521-528.
59. Elias MF, Elias PK, Sullivan LM, Wolf PA and D'Agostino RB (2005) Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiology of aging 26 Suppl 1:11-16.
60. Engelhardt JI, Tajti J and Appel SH (1993) Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Archives of neurology 50:30-36.
61. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC and Breteler MM (2004) Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Archives of neurology 61:668-672.
62. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD and Cawthon RM (2004) Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 101:17312-17315.
63. Erion JR, Wosiski-Kuhn M, Dey A, Hao S, Davis CL, Pollock NK and Stranahan AM (2014) Obesity elicits interleukin 1-mediated deficits in hippocampal synaptic plasticity. The Journal of neuroscience: the official journal of the Society for Neuroscience 34:2618-2631.
64. Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK and Stefanova N (2013) Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia. Glia 61:349-360.
65. Felten DL, Felten SY, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, Olschowki JA and Livnat S (1987) Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunological reviews 100:225-260.
66. Ferretti MT, Bruno MA, Ducatenzeiler A, Klein WL and Cuello AC (2012) Intracellular Abeta-oligomers and early inflammation in a model of Alzheimer's disease. Neurobiology of aging 33:1329-1342.
67. Festa A, D'Agostino R, Jr., Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP and Haffner SM (2001) The relation of body fat mass and distribution to markers of chronic inflammation. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 25:1407-1415.
68. Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, Lossinsky AS, Graves MC, Gustavson A, Sayre J, Sofroni E, Suarez T, Chiappelli F and Bernard G (2005) Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. Journal of Alzheimer's disease: JAD 7:221-232; discussion 255-262.
69. Flanary BE, Sammons NW, Nguyen C, Walker D and Streit WJ (2007) Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation research 10:61-74.
70. Fontana L and Partridge L (2015) Promoting Health and Longevity through Diet: From Model Organisms to Humans. Cell 161:106-118.
71. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E and De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences 908:244-254.
72. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC and Salvioli S (2007) Inflammaging and antiinflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128:92-105.
73. Frasca D, Diaz A, Romero M, Landin AM and Blomberg BB (2011) Age effects on B cells and humoral immunity in humans. Ageing research reviews 10:330-335.
74. Freund A, Orjalo AV, Desprez PY and Campisi J (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends in molecular medicine 16:238-246.
75. Friedman JM and Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763-770.
76. Fulop T, Larbi A, Douziech N, Fortin C, Guerard KP, Lesur O, Khalil A and Dupuis G (2004) Signal transduction and functional changes in neutrophils with aging. Aging cell 3:217-226.
77. Fulop T, Larbi A and Pawelec G (2013) Human T cell aging and the impact of persistent viral infections. Frontiers in immunology 4:271.
78. Gao X, Chen H, Schwarzschild MA and Ascherio A (2011) Use of ibuprofen and risk of Parkinson disease. Neurology 76:863-869.
79. Gemechu JM and Bentivoglio M (2012) T Cell Recruitment in the Brain during Normal Aging. Frontiers in cellular neuroscience 6:38.
80. Gerard HC, Wildt KL, Whittum-Hudson JA, Lai Z, Ager J and Hudson AP (2005) The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microbial pathogenesis 39:19-26.
81. Ghosh S, Lertwattanarak R, Lefort N, Molina-Carrion M, Joya-Galeana J, Bowen BP, Garduno-Garcia Jde J, Abdul-Ghani M, Richardson A, DeFronzo RA, Mandarino L, Van Remmen H and Musi N (2011) Reduction in reactive oxygen species production by mitochondria from elderly subjects with normal and impaired glucose tolerance. Diabetes 60:2051-2060.
82. Glaser R and Kiecolt-Glaser JK (2005) Stress-induced immune dysfunction: implications for health. Nature reviews Immunology 5:243-251.
83. Goronzy JJ, Li G, Yu M and Weyand CM (2012) Signaling pathways in aged T cells-a reflection of T cell differentiation, cell senescence and host environment. Seminars in immunology 24:365-372.
84. Green DR, Galluzzi L and Kroemer G (2011) Mitochondria and the autophagyinflammation- cell death axis in organismal aging. Science 333:1109-1112.
85. Griffioen KJ, Rothman SM, Ladenheim B, Wan R, Vranis N, Hutchison E, Okun E, Cadet JL and Mattson MP (2013) Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant alpha-synuclein. Neurobiology of aging 34:928-935.
86. Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, Zondler L, Brenner D, Martin-Villalba A, Hengerer B, Kassubek J, Ludolph AC, Weishaupt JH and Danzer KM (2014) Inflammatory dysregulation of blood monocytes in Parkinson's disease patients. Acta neuropathologica 128:651-663.
87. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, Walker B, Sullivan J, Phillips R, Pape GR and Klenerman P (2001) Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 75:5550-5558.
88. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J and Alzheimer Genetic Analysis G (2013) TREM2 variants in Alzheimer's disease. The New England journal of medicine 368:117-127.
89. Gustafson DR, Karlsson C, Skoog I, Rosengren L, Lissner L and Blennow K (2007) Mid-life adiposity factors relate to blood-brain barrier integrity in late life. Journal of internal medicine 262:643-650.
90. Hagberg H, Mallard C, Ferriero DM, Vannucci SJ, Levison SW, Vexler ZS and Gressens P (2015) The role of inflammation in perinatal brain injury. Nature reviews Neurology.
91. Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, Kusel VI, Collura R, Roberts J, Griffith A, Samii A, Scott WK, Nutt J, Factor SA and Payami H (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nature genetics 42:781-785.
92. Handschin C and Spiegelman BM (2008) The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454:463-469.
93. Hannestad J, Gallezot JD, Schafbauer T, Lim K, Kloczynski T, Morris ED, Carson RE, Ding YS and Cosgrove KP (2012) Endotoxin-induced systemic inflammation activates microglia: [(1)(1)C]PBR28 positron emission tomography in nonhuman primates. NeuroImage 63:232-239.
94. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Dolan RJ and Critchley HD (2009) Neural origins of human sickness in interoceptive responses to inflammation. Biological psychiatry 66:415-422.
95. Hart AD, Wyttenbach A, Perry VH and Teeling JL (2012) Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences. Brain, behavior, and immunity 26:754-765.
96. Hassing LB, Dahl AK, Pedersen NL and Johansson B (2010) Overweight in midlife is related to lower cognitive function 30 years later: a prospective study with longitudinal assessments. Dementia and geriatric cognitive disorders 29:543-552.
97. Hearps AC, Martin GE, Angelovich TA, Cheng WJ, Maisa A, Landay AL, Jaworowski A and Crowe SM (2012) Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging cell 11:867-875.
98. Hedstrom AK, Lima Bomfim I, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I, Olsson T and Alfredsson L (2014) Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology 82:865-872.
99. Hefendehl JK, Neher JJ, Suhs RB, Kohsaka S, Skodras A and Jucker M (2014) Homeostatic and injury-induced microglia behavior in the aging brain. Aging cell 13:60-69.
100. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR and Appel SH (2004) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55:221-235.
101. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Jr., Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P, HIV OARWGo and Aging (2012) HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. Journal of acquired immune deficiency syndromes 60 Suppl 1:S1-18.
102. Hong S and Banks WA (2015) Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain, behavior, and immunity 45:1-12.
103. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860-867.
104. Hottman DA, Chernick D, Cheng S, Wang Z and Li L (2014) HDL and cognition in neurodegenerative disorders. Neurobiol Dis 72 Pt A:22-36.
105. Hu G, Antikainen R, Jousilahti P, Kivipelto M and Tuomilehto J (2008) Total cholesterol and the risk of Parkinson disease. Neurology 70:1972-1979.
106. Hu G, Jousilahti P, Nissinen A, Antikainen R, Kivipelto M and Tuomilehto J (2006) Body mass index and the risk of Parkinson disease. Neurology 67:1955-1959.
107. in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM and Stricker BH (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. The New England journal of medicine 345:1515-1521.
108. International Schizophrenia C, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF and Sklar P (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748-752.
109. Irish Schizophrenia Genomics C and the Wellcome Trust Case Control C (2012) Genomewide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biological psychiatry 72:620-628.
110. Itzhaki RF and Wozniak MA (2006) Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders. Progress in lipid research 45:73-90.
111. Jang H, Boltz DA, Webster RG and Smeyne RJ (2009) Viral parkinsonism. Biochimica et biophysica acta 1792:714-721.
112. Jeong SK, Nam HS, Son MH, Son EJ and Cho KH (2005) Interactive effect of obesity indexes on cognition. Dementia and geriatric cognitive disorders 19:91-96.
113. Joachim CL and Selkoe DJ (1992) The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis Assoc Disord 6:7-34.
114. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A and Stefansson K (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. The New England journal of medicine 368:107-116.
115. Jun JI and Lau LF (2010) The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nature cell biology 12:676-685.
116. Jyonouchi H, Geng L, Streck DL and Toruner GA (2012) Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study. Journal of neuroinflammation 9:4.
117. Karabatsiakis A, Kolassa IT, Kolassa S, Rudolph KL and Dietrich DE (2014) Telomere shortening in leukocyte subpopulations in depression. BMC psychiatry 14:192.
118. Kayser MS and Dalmau J (2011) The emerging link between autoimmune disorders and neuropsychiatric disease. The Journal of neuropsychiatry and clinical neurosciences 23:90-97.
119. Kepp O, Galluzzi L and Kroemer G (2011) Mitochondrial control of the NLRP3 inflammasome. Nature immunology 12:199-200.
120. Kettenmann H, Hanisch UK, Noda M and Verkhratsky A (2011) Physiology of microglia. Physiological reviews 91:461-553.
121. Koch S, Larbi A, Ozcelik D, Solana R, Gouttefangeas C, Attig S, Wikby A, Strindhall J, Franceschi C and Pawelec G (2007) Cytomegalovirus infection: a driving force in human T cell immunosenescence. Annals of the New York Academy of Sciences 1114:23-35.
122. Kota LN, Purushottam M, Moily NS and Jain S (2014) Shortened telomere in unremitted schizophrenia. Psychiatry and clinical neurosciences.
123. Kotrschal A, Ilmonen P and Penn DJ (2007) Stress impacts telomere dynamics. Biology letters 3:128-130.
124. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN and Vandenabeele P (2011) Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends in immunology 32:157-164.
125. Kuk JL, Saunders TJ, Davidson LE and Ross R (2009) Age-related changes in total and regional fat distribution. Ageing research reviews 8:339-348.
126. Landreth GE and Reed-Geaghan EG (2009) Toll-like receptors in Alzheimer's disease. Current topics in microbiology and immunology 336:137-153.
127. Larbi A, Pawelec G, Wong SC, Goldeck D, Tai JJ and Fulop T (2011) Impact of age on T cell signaling: a general defect or specific alterations? Ageing research reviews 10:370-378.
128. Le Garff-Tavernier M, Beziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, Debre P, Merle-Beral H and Vieillard V (2010) Human NK cells display major phenotypic and functional changes over the life span. Aging cell 9:527-535.
129. Lederman MM, Funderburg NT, Sekaly RP, Klatt NR and Hunt PW (2013) Residual immune dysregulation syndrome in treated HIV infection. Adv Immunol 119:51-83.
130. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T and Malik M (2009) Elevated immune response in the brain of autistic patients. Journal of neuroimmunology 207:111-116.
131. Liao B, Zhao W, Beers DR, Henkel JS and Appel SH (2012) Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Experimental neurology 237:147-152.
132. Loftis JM, Huckans M, Ruimy S, Hinrichs DJ and Hauser P (2008) Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin- 1beta and tumor necrosis factor-alpha. Neuroscience letters 430:264-268.
133. Lopez-Armada MJ, Riveiro-Naveira RR, Vaamonde-Garcia C and Valcarcel-Ares MN (2013) Mitochondrial dysfunction and the inflammatory response. Mitochondrion 13:106-118.
134. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR and Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394:897-901.
135. Lukiw WJ (2004) Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochemical research 29:1287-1297.
136. Lynch MA (2010) Age-related neuroinflammatory changes negatively impact on neuronal function. Frontiers in aging neuroscience 1:6.
137. Maggio M, Basaria S, Ble A, Lauretani F, Bandinelli S, Ceda GP, Valenti G, Ling SM and Ferrucci L (2006) Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. The Journal of clinical endocrinology and metabolism 91:345-347.
138. Margaretten M, Julian L, Katz P and Yelin E (2011) Depression in patients with rheumatoid arthritis: description, causes and mechanisms. International journal of clinical rheumatology 6:617-623.
139. Maswood N, Young J, Tilmont E, Zhang Z, Gash DM, Gerhardt GA, Grondin R, Roth GS, Mattison J, Lane MA, Carson RE, Cohen RM, Mouton PR, Quigley C, Mattson MP and Ingram DK (2004) Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc Natl Acad Sci U S A 101:18171-18176.
140. Mathew A, Lindsley TA, Sheridan A, Bhoiwala DL, Hushmendy SF, Yager EJ, Ruggiero EA and Crawford DR (2012) Degraded mitochondrial DNA is a newly identified subtype of the damage associated molecular pattern (DAMP) family and possible trigger of neurodegeneration. Journal of Alzheimer's disease: JAD 30:617-627.
141. McGeer PL and McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26:459-470.
142. Mekker A, Tchang VS, Haeberli L, Oxenius A, Trkola A and Karrer U (2012) Immune senescence: relative contributions of age and cytomegalovirus infection. PLoS Pathog 8:e1002850.
143. Mercken EM, Crosby SD, Lamming DW, JeBailey L, Krzysik-Walker S, Villareal DT, Capri M, Franceschi C, Zhang Y, Becker K, Sabatini DM, de Cabo R and Fontana L (2013) Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile. Aging cell 12:645-651.
144. Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, Koenigsknecht-Talboo J, Holtzman DM, Bacskai BJ and Hyman BT (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 451:720-724.
145. Miller BJ, Buckley P, Seabolt W, Mellor A and Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biological psychiatry 70:663-671.
146. Montecino-Rodriguez E, Berent-Maoz B and Dorshkind K (2013) Causes, consequences, and reversal of immune system aging. The Journal of clinical investigation 123:958-965.
147. Perry VH and Holmes C (2014) Microglial priming in neurodegenerative disease. Nature reviews Neurology 10:217-224.
148. Perry VH, Matyszak MK and Fearn S (1993) Altered antigen expression of microglia in the aged rodent CNS. Glia 7:60-67.
149. Phillips C, Baktir MA, Srivatsan M and Salehi A (2014) Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. Frontiers in cellular neuroscience 8:170.
150. Pohl J, Woodside B and Luheshi GN (2014) Leptin modulates the late fever response to LPS in diet-induced obese animals. Brain, behavior, and immunity 42:41-47.
151. Rao SR (2012) Inflammatory markers and bariatric surgery: a meta-analysis. Inflammation research: official journal of the European Histamine Research Society [et al] 61:789-807.
152. Ravenholt RT and Foege WH (1982) 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 2:860-864.
153. Razay G, Vreugdenhil A and Wilcock G (2007) The metabolic syndrome and Alzheimer disease. Archives of neurology 64:93-96.
154. Reed-Geaghan EG, Savage JC, Hise AG and Landreth GE (2009) CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. The Journal of neuroscience: the official journal of the Society for Neuroscience 29:11982-11992.
155. Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE and Ben-Shlomo Y (2011) Nonsteroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies. The Cochrane database of systematic reviews:CD008454.
156. Roberts ET, Haan MN, Dowd JB and Aiello AE (2010) Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. American journal of epidemiology 172:363-371.
157. Rodriguez GA, Tai LM, LaDu MJ and Rebeck GW (2014) Human APOE4 increases microglia reactivity at Abeta plaques in a mouse model of Abeta deposition. Journal of neuroinflammation 11:111.
158. Rotermund C, Truckenmuller FM, Schell H and Kahle PJ (2014) Diet-induced obesity accelerates the onset of terminal phenotypes in alpha-synuclein transgenic mice. Journal of neurochemistry 131:848-858.
159. Ryan AS and Nicklas BJ (2004) Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes care 27:1699-1705.
160. Santiago JA and Potashkin JA (2013) Shared dysregulated pathways lead to Parkinson's disease and diabetes. Trends in molecular medicine 19:176-186.
161. Saunders JA, Estes KA, Kosloski LM, Allen HE, Dempsey KM, Torres-Russotto DR, Meza JL, Santamaria PM, Bertoni JM, Murman DL, Ali HH, Standaert DG, Mosley RL and Gendelman HE (2012) CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease. J Neuroimmune Pharmacol 7:927-938.
162. Schwarcz R, Bruno JP, Muchowski PJ and Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nature reviews Neuroscience 13:465-477.
163. Sczelecki S, Besse-Patin A, Abboud A, Kleiner S, Laznik-Bogoslavski D, Wrann CD, Ruas JL, Haibe-Kains B and Estall JL (2014) Loss of Pgc-1alpha expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation. American journal of physiology Endocrinology and metabolism 306:E157-167.
164. Sharma A, Valadi N, Miller AH and Pearce BD (2002) Neonatal viral infection decreases neuronal progenitors and impairs adult neurogenesis in the hippocampus. Neurobiol Dis 11:246-256.
165. Shaw AC, Goldstein DR and Montgomery RR (2013) Age-dependent dysregulation of innate immunity. Nature reviews Immunology 13:875-887.
166. Sheffield LG and Berman NE (1998) Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiology of aging 19:47-55.
167. Sheng JG, Mrak RE and Griffin WS (1998) Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta neuropathologica 95:229-234.
168. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, Rentsendorj A, Vargas M, Guerrero C, Wang Y, Fitzgerald KA, Underhill DM, Town T and Arditi M (2012) Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36:401-414.
169. Simard AR, Soulet D, Gowing G, Julien JP and Rivest S (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49:489-502.
170. Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M and Wong KK (2006) Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biological psychiatry 60:432-435.
171. Simopoulos AP (2002) The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 56:365-379.
172. Singh-Manoux A, Dugravot A, Brunner E, Kumari M, Shipley M, Elbaz A and Kivimaki M (2014) Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology 83:486-493.
173. Skilton MR, Moulin P, Terra JL and Bonnet F (2007) Associations between anxiety, depression, and the metabolic syndrome. Biological psychiatry 62:1251-1257.
174. Soderlund J, Schroder J, Nordin C, Samuelsson M, Walther-Jallow L, Karlsson H, Erhardt S and Engberg G (2009) Activation of brain interleukin-1beta in schizophrenia. Molecular psychiatry 14:1069-1071.
175. Stefanova N, Fellner L, Reindl M, Masliah E, Poewe W and Wenning GK (2011) Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons. Am J Pathol 179:954-963.
176. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS and Glaser R (2007) Chronic herpesvirus reactivation occurs in aging. Experimental gerontology 42:563-570.
177. Streit WJ, Braak H, Xue QS and Bechmann I (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta neuropathologica 118:475-485.
178. Streit WJ, Sammons NW, Kuhns AJ and Sparks DL (2004) Dystrophic microglia in the aging human brain. Glia 45:208-212.
179. Strohmeyer R, Ramirez M, Cole GJ, Mueller K and Rogers J (2002) Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain. Journal of neuroimmunology 131:135-146.
180. Sundelof J, Kilander L, Helmersson J, Larsson A, Ronnemaa E, Degerman-Gunnarsson M, Basun H, Lannfelt L and Basu S (2009) Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study. Journal of Alzheimer's disease: JAD 18:79-87.
181. Sutedja NA, van der Schouw YT, Fischer K, Sizoo EM, Huisman MH, Veldink JH and Van den Berg LH (2011) Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:638-642.
182. Sutherland GT, Chami B, Youssef P and Witting PK (2013) Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product? Redox Rep 18:134-141.
183. Suzuki Y, Wang X, Jortner BS, Payne L, Ni Y, Michie SA, Xu B, Kudo T and Perkins S (2010) Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. Am J Pathol 176:1607-1613.
184. Szekely CA, Breitner JC, Fitzpatrick AL, Rea TD, Psaty BM, Kuller LH and Zandi PP (2008) NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology 70:17-24.
185. Szweda PA, Camouse M, Lundberg KC, Oberley TD and Szweda LI (2003) Aging, lipofuscin formation, and free radical-mediated inhibition of cellular proteolytic systems. Ageing research reviews 2:383-405.
186. Takahashi K, Rochford CD and Neumann H (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. The Journal of experimental medicine 201:647-657.
187. Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, Benjamin EJ, Au R, Kiel DP, Wolf PA and Seshadri S (2007) Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 68:1902-1908.
188. Tchernof A and Despres JP (2013) Pathophysiology of human visceral obesity: an update. Physiological reviews 93:359-404.
189. Tchkonia T, Zhu Y, van Deursen J, Campisi J and Kirkland JL (2013) Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. The Journal of clinical investigation 123:966-972.
190. Thewissen M, Linsen L, Somers V, Geusens P, Raus J and Stinissen P (2005) Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Annals of the New York Academy of Sciences 1051:255-262.
191. Thewissen M, Somers V, Venken K, Linsen L, van Paassen P, Geusens P, Damoiseaux J and Stinissen P (2007) Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol 123:209-218.
192. Torrey EF, Bartko JJ and Yolken RH (2012) Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophrenia bulletin 38:642-647.
193. Trayhurn P and Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. The British journal of nutrition 92:347-355.
194. Troost D, van den Oord JJ, de Jong JM and Swaab DF (1989) Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clinical neuropathology 8:289-294.
195. Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M and Colonna M (2006) Cutting edge: TREM-2 attenuates macrophage activation. Journal of immunology 177:3520-3524.
196. Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN and Banati RB (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15:601-609.
197. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D and Krishnan R (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:29-35.
198. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW and Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:67-81.
199. von Bernhardi R, Tichauer JE and Eugenin J (2010) Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. Journal of neurochemistry 112:1099-1114.
200. Wahner AD, Bronstein JM, Bordelon YM and Ritz B (2007) Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology 69:1836-1842.
201. Wake H, Moorhouse AJ, Jinno S, Kohsaka S and Nabekura J (2009) Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. The Journal of neuroscience: the official journal of the Society for Neuroscience 29:3974-3980.
202. Walker FR (2013) A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology 67:304-317.
203. Wang C, Maddick M, Miwa S, Jurk D, Czapiewski R, Saretzki G, Langie SA, Godschalk RW, Cameron K and von Zglinicki T (2010) Adult-onset, short-term dietary restriction reduces cell senescence in mice. Aging 2:555-566.
204. Watkins CC and Treisman GJ (2012) Neuropsychiatric complications of aging with HIV. Journal of neurovirology 18:277-290.
205. Weissenborn K, Ennen JC, Bokemeyer M, Ahl B, Wurster U, Tillmann H, Trebst C, Hecker H and Berding G (2006) Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut 55:1624-1630.
206. Wenisch C, Patruta S, Daxbock F, Krause R and Horl W (2000) Effect of age on human neutrophil function. Journal of leukocyte biology 67:40-45.
207. Wilson CJ, Finch CE and Cohen HJ (2002) Cytokines and cognition--the case for a headto- toe inflammatory paradigm. J Am Geriatr Soc 50:2041-2056.
208. Witte AV, Fobker M, Gellner R, Knecht S and Floel A (2009) Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci U S A 106:1255-1260.
209. Wong WT (2013) Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation. Frontiers in cellular neuroscience 7:22.
210. Wright AL, Zinn R, Hohensinn B, Konen LM, Beynon SB, Tan RP, Clark IA, Abdipranoto A and Vissel B (2013) Neuroinflammation and neuronal loss precede Abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. PloS one 8:e59586.
211. Wrona D (2006) Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. Journal of neuroimmunology 172:38-58.
212. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nature medicine 12:1005-1015.
213. Xu H, Chen M, Manivannan A, Lois N and Forrester JV (2008) Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging cell 7:58-68.
214. Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A and Chen H (2011) Diabetes and risk of Parkinson's disease. Diabetes care 34:910-915.
215. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C and Lowe SW (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445:656-660.
216. Ye SM and Johnson RW (2001) An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation 9:183-192.
217. Yolken RH and Torrey EF (2008) Are some cases of psychosis caused by microbial agents? A review of the evidence. Molecular psychiatry 13:470-479.
218. Youm YH, Grant RW, McCabe LR, Albarado DC, Nguyen KY, Ravussin A, Pistell P, Newman S, Carter R, Laque A, Munzberg H, Rosen CJ, Ingram DK, Salbaum JM and Dixit VD (2013) Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell metabolism 18:519-532.
219. Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, D'Agostino D, Planavsky N, Lupfer C, Kanneganti TD, Kang S, Horvath TL, Fahmy TM, Crawford PA, Biragyn A, Alnemri E and Dixit VD (2015) The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nature medicine.
220. Yudkin JS, Stehouwer CD, Emeis JJ and Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, thrombosis, and vascular biology 19:972-978.
221. Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC and Cache County Study I (2002) Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology 59:880-886.
222. Zapata HJ and Shaw AC (2014) Aging of the human innate immune system in HIV infection. Curr Opin Immunol 29:127-136.
223. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, DiMarchi RD, Furman TC, Hale JE, Hsiung HM, Schoner BE, Smith DP, Zhang XY, Wery JP and Schevitz RW (1997) Crystal structure of the obese protein leptin-E100. Nature 387:206-209.